Wave Life Sciences Ltd.

NASDAQ:WVE

Biotechnology

Healthcare
$2.72 +1.63%

+$0.10 today

Market cap
$536.46M
Beta
-1.33
P/E (TTM)
-6.6
EPS (TTM)
-$0.92
52W Low $5.02High $21.73

Volume 1.92M

Average 4.86M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$187.49M

FY 2025 · Annual

Investing Cash Flow

-$718,000.00

FY 2025 · Annual

Financing Cash Flow

$488.24M

FY 2025 · Annual

+92.3% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(122.25M)(161.82M)(57.51M)(97.01M)(204.38M)
Depreciation & Amortization9.84M10.11M9.21M8.66M8.85M
Deferred Income Tax(12.64M)0000
Stock-Based Compensation16.41M17.19M9.8M13.14M0
Change in Working Capital7.01M6.72M19.08M(75.82M)(16.94M)
Accounts Receivables30M0(21.09M)19.66M146K
Inventory2.04M0000
Accounts Payables(6.57M)9.35M(3.76M)3.42M(561K)
Other Working Capital(18.46M)(2.63M)43.93M(98.91M)(16.53M)
Other Non-Cash Items12.64M12K0024.97M
Operating Cash Flow(88.99M)(127.78M)(19.43M)(151.03M)(187.49M)
Capital Expenditures(560K)(1.36M)(1.12M)(938K)(718K)
Acquisitions (Net)00000
Purchases of Investments0(75.04M)000
Sales of Investments075.04M000
Other Investing Activities0106K000
Investing Cash Flow(560K)(1.26M)(1.12M)(938K)(718K)
Debt Repayment00000
Common Stock Issued54.97M52.33M131.28M236.18M488.24M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities858K14.86M1.26M17.71M0
Financing Cash Flow55.83M67.19M132.53M253.89M488.24M
Effect of Forex Changes(208K)(210K)(95K)(138K)12K
Net Change in Cash(33.93M)(62.06M)111.89M101.79M300.04M
Free Cash Flow(89.55M)(129.14M)(20.55M)(151.96M)(187.49M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$204.4M
+ D&A$8.9M
+ Stock-Based Comp$0
+ Deferred Tax$0
- Working Capital-$16.9M
+ Other Non-Cash$25.0M
= Operating Cash Flow-$187.5M
- Capex-$718.0K
= Free Cash Flow-$187.5M

Analysis

FY2025 free cash flow is -$187.5M. FCF conversion is 91.7% of net income. Operating cash flow was -$187.5M, with capex of -$718.0K. The largest bridge item is Other Non-Cash at $25.0M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingOct 27, 2026
8-KCurrent reportOct 27, 2026
10-QQuarterly reportOct 27, 2026
SC 13G/ASC 13G/A filingOct 27, 2026
ARSARS filingOct 14, 2026

Does WVE generate free cash flow?

Wave Life Sciences Ltd. (WVE) generated -$187.49M of free cash flow in fiscal 2025.

How much operating cash flow does WVE produce?

Operating cash flow was -$187.49M, before capital expenditures of $718,000.00.